Open Label Ustekinumab for the Treatment of Anti-TNFα Refractory Moderate-to-Severe Crohnʼs Disease
The American Journal of Gastroenterology（2011）
Key words
Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined